BioSpace News Archive

Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced the start of data analysis of the multi-center, global Phase III AGENT Study investigating arfolitixorin in combination with 5-FU, oxaliplatin and bevacizumab in advanced, metastatic colorectal cancer (mCRC).

Frequency Therapeutics, Inc. today announced that Chief Scientific Officer Dr. Christopher Loose and Vice President of Discovery Biology Dr. Sanjay Magavi will participate in a fireside presentation at the B. Riley Securities’ Neuro & Ophthalmology Conference on April 28, 2022 at 3:30 pm ET.

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, announced the appointment of Amrit Ray, M.D., M.B.A. to the company’s Board of Directors.

Jasper Therapeutics, Inc. today announced that it will host an in-person key opinion leader (KOL) webinar on transforming the field of hematopoietic stem cell therapies on April 28, 2022, at 1:00 p.m. ET.

Albany NY, United States: Transparency Market Research has ublished a new report titled, “Dermal Fillers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

DUBAI, United Arab Emirates, Anaphylactic shock is the most common chronic disease in Europe and North America region.

Albany NY, United States: The global market for allergy immunotherapy was initially valued at US$1.37 bn back in the year 2016.

Albany NY, United States: Noteworthy growth in the incidences of neurological disorders and autoimmune diseases across the globe is projected to help in the expansion of the global intravenous immunoglobulin market, according to a new study published by TMR.

Albany NY, United States: A report by Transparency Market Research throws light on the key dynamics operating within the global market for wearable injectors.

Takeda (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present four company-sponsored abstracts at the Tandem Transplantation & Cellular Therapy Meetings in Salt Lake City, Utah, and the 32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Lisbon, Portugal between April 23 and 26, 2022.